Here's what is coming soon to NeurologyLive.
Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week.
On Tuesday, December 22, 2020, an open letter from Barry J. Byrne, MD, PhD, chief medical advisor, Muscular Dystrophy Association, calls for the prioritization of persons with neuromuscular diseases as early candidates for the COVID-19 vaccination implementation, will go live on the site.
To catch up on some of our conversations with Byrne, click here.
This week’s NeuroVoices features Brian Wainger, MD, PhD, assistant professor, Harvard Medical Center, principal investigator, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, who discussed the phase 2 data of ezogabine, a drug which showed decreases of cortical and spinal motor neuron excitability in patients with ALS. He provided in-depth detail of the study, along with the history of ezogabine as a treatment for partial-onset seizures, and how motor neuron excitability can be studied in the future.
To check out the prior NeuroVoices conversations, click here.
To review how the global pandemic affected neurology and the communities within it, we’ve developed “Reflections on the Impact of COVID-19: A Short Expert Series.” Over this week, each day we will be launching pieces dedicated to some of the major topics surrounding the pandemic, with links to some of our most notable interviews and conversations with clinicians from throughout the year.
To check out each piece in the series, click here.
Our new video series, “The Multiple Sclerosis Patient Journey” also launches this Wednesday! The series features a panel that includes experts such as June Halper, MSN, MSCN, Fredrick Foley, PhD, and Patricia Coyle, MD. Ann Moore, a patient with multiple sclerosis, and Kathy Zelles, her care partner, join the panel as well to discuss Moore’s unique journey and provide first-hand experience of what it’s like to live with MS.
To check out all of our patient-centered series, click here.
A conversation with Merit Cudkowicz, MD, chief, Neurology Department, director, Sean M. Healey & AMG Center for ALS, and director, Neurological Clinical Research Institute, will air during NeurologyLive's segment on the Medical World News channel this Thursday, December 24, 2020. Cudkowicz discussed the latest phase 3 data on NurOwn in the treatment of patients with ALS.
To check out what's on the Medical World News channel now, click here.